Page 68 - Iontech News Today

BERLIN (AP) — Most COVID-19 patients in intensive care in German hospitals arent...

BERLIN (AP) — Most COVID-19 patients in intensive care in German hospitals arent...

The risk of severe side effects from booster was estimated to be very low

BioNTech SE and Tunisian InstaDeep Ltd announced on Tuesday the development of a new computational method that analyses worldwide available sequencing data and predicts high-risk variants of... | January 12, 2022

Two of the 36 reported gastrointestinal discomfort after receiving the BioNTech vaccine at a clinic in Tin Shui Wai.

While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.

Helped by sales of COVID-19 treatments, Regeneron reported being in a

BioNTech and Crescendo, a clinical stage immuno-oncology company developing targeted T cell enhancing therapeutics, have entered a multi-target discovery collaboration to develop novel immunotherapies for cancer and other diseases.

ROME (AP) — Pope Francis suggested Monday that getting vaccinated against the...

ROME (AP) — Pope Francis suggested Monday that getting vaccinated against the...